Thematic area:
Smart Implants and Devices
Product:
Next-generation flexible microwire electrode arrays designed for responsive neurostimulation (RNS) in epilepsy. LIVEWIRE integrates conductive nanomaterials and biomimetic, immunomodulatory hydrogels to reduce scarring, improve signal quality, and enhance long-term neural integration.
Market:
The epilepsy device market is projected to reach €11.7B by 2030. The technology is attractive to neurostimulation manufacturers, neurosurgical centres, and implantable device companies seeking improved neural interfaces.
Fit:
Current electrodes suffer from inflammation, fibrotic encapsulation, and signal degradation. LIVEWIRE’s tissue friendly, antimicrobial, flexible design directly addresses these issues and could meaningfully improve RNS outcomes. Well-positioned for licensing or spinout following successful in vivo validation.
